Cerebrospinal fluid virology in people with HIV
HIV Medicine · 2023
DOI: 10.1111/hiv.13471 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2023. Verfasst von Merle Henderson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Faculty of Medicine, St Mary's Campus, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Herpesviridae Infections, Epstein-Barr Virus Infections, HIV Infections, Cytomegalovirus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Our objectives were to investigate the recent frequency of cerebrospinal fluid (CSF) HIV RNA escape and other CSF viral nucleic acid detection in people with HIV with neurological symptoms and to assess associated clinical factors.
Method
This was a retrospective cohort analysis of people with HIV who underwent CSF examination for clinical indications between 2017 and 2022. Individuals were identified from pathology records, and clinical data were recorded. CSF HIV RNA escape was defined as CSF HIV RNA concentrations greater than in plasma. CSF viral screen included herpes simplex virus types 1 (HSV‐1) and 2 (HSV‐2), varicella zoster virus (VZV), Epstein Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus 6 (HHV‐6) and JC virus. When cases were detected in five or more people with HIV, associated clinical factors were assessed using linear regression modelling.
Results
CSF HIV RNA escape was observed in 19 of 114 individuals (17%) and was associated with the presence of HIV drug resistance mutations and non‐integrase strand transfer inhibitor‐based antiretroviral therapy ( p < 0.05 for all) when compared to people with HIV without escape. Positive viral nucleic acid testing included EBV ( n = 10), VZV (3), CMV (2), HHV‐6 (2) and JC virus (4). Detectable CSF EBV was not considered related to neurological symptoms and was associated with concomitant CSF infections in eight of ten individuals and with CSF pleocytosis, previous AIDS, lower nadir and current CD4 T‐cell count ( p < 0.05 for all).
Conclusion
In people with HIV with neurological symptoms, the frequency of CSF HIV RNA escape remains similar to that in historical reports. Detectable EBV viral nucleic acid in the CSF was observed frequently and, in the absence of clinical manifestations, may be a consequence of CSF pleocytosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Disease, Faculty of Medicine, St Mary's Campus, Imperial College London, London, UK.
- Department of HIV and GU Medicine, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
- North West London Pathology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
- Department of Neurology, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
ORCID-Profile: Merle Henderson, Alan Winston
Zitieren
APA
Henderson, M., Pepper, N., Bawa, M., Muir, D., Everitt, A., Mackie, N. E., & Winston, A. (2023). Cerebrospinal fluid virology in people with HIV. HIV Medicine. https://doi.org/10.1111/hiv.13471
Vancouver
Henderson M, Pepper N, Bawa M, Muir D, Everitt A, Mackie NE, et al. Cerebrospinal fluid virology in people with HIV. HIV Medicine. 2023. doi:10.1111/hiv.13471
BibTeX
@article{Henderson2023,
author = {Henderson, Merle and Pepper, Nuala and Bawa, Manraj and Muir, David and Everitt, Alex and Mackie, Nicola E and Winston, Alan},
title = {Cerebrospinal fluid virology in people with HIV},
journal = {HIV Medicine},
year = {2023},
doi = {10.1111/hiv.13471}
}
EUVIMED